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ing the linear-quadratic model ratios): V45.4/ (assuming the previous<50%, V54.5 < 35%, V59.0 < 25%, V63.6 < 20%, V68.2 < 50%
for rectum; V59.0 < 50%, V63.6 < 35%, V68.2 < 25%, V72.7 < 15% for bladder; Dmax<45.4Gy for femoral heads; Dmean<45.4Gy for
penile bulb. Valid singleVMATarcplans are generatedby theTPS. Target volumespreserve theoptimalhomogeneity andcoverage,
as well as OARs maintain their dose–volume parameters under those imposed by QUANTEC: 3.1)%, ±4.0)%, V63.6 = (6.5±4.4)%,
V59.0 = (8.9±5.9)%, V54.5 = (11.7±V45.4 = (20.3 6.5)%,±7.3)%, V63.6 = (9.5±2.4)% for rectum; V59.0 = (12.2±V68.2 = (4.1 4.6)Gy for
femoral±4.0)% for bladder; Dmax= (35.3±5.6)%, V72.7 = (2.7±V68.2 = (6.5 3.7) Gy for penile bulb. Mean treatment time is 310±43
s.±heads; Dmean= (42.3 VMAT in conjunction with IGRT techniques are powerful tools to cover a hypofractionated prostate
cancer treatment program. It is possible to generate optimal plans to treat target volumes as well as to accomplish QUANTEC
constraints. VMAT treatment technique allows the delivery of the treatment in a single arc, with a signiﬁcant reduction in
treatment time.
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Introduction. The National Radiotherapy Advisory Group (NRAG) of the U.K. recommended that 24% of all radical fractions (32%
of patients) should be delivered with inverse planned IMRT as target for quality radiotherapy care indicator.1
Objective. To analyse the inverse planned IMRT (IP-IMRT) pattern in our center and compare the results to the NRAG recommen-
dations.
Patients & methods. The radiation oncology unit at Alcazar de San Juan covers a population of 203.233 in-habitants censored in
2011. From Jan to Dec 2011 a total of 344 patients were referred for radiation therapy, 106 of these with palliative intent and were
excluded as IP-MRT was not used for palliation.
Results. 36.9% of patients (88 out of 238) received IP-IMRT with radical intent (deﬁne as exclusive & pre or postoperative radiothe-
rapy), accounting for 31.7% of the total number of fractions administered. The technique used was hypofractionated SIB-IMRT in
71.5% of pts and a standard fraction one phase IMRT in 27.3%. According to primary tumor localization the IP-IMRT distribution
was: Prostate 42%, rectal cancer 32% (SIB-IMRT dose escalation study), HNC 15%, Gynecologic cancers 8%. The IMRT use by tumor
site was: Proste 100%, Rectal 82%, HNC 76%, Gynecol 77%. Distribution by treatment intention was as follows: RT only 34.5%,
preoperative 32%, postoperative 23%, cancer local relapse 11%.
Conclusion. Use of IP-IMRT in our center is quite similar to the NRAG recommendations and greater than the 9.9% (8.5% IP-
IMRT+1.4%VMAT) of a recent survey in theUK2 or the 6.2%use in France.3 This benchmarking study allowsus future comparisons
in changing scenarios as reimbursement modiﬁcations or economical constraints.
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Purpose. Keloid represents a signiﬁcant bother for patients and a therapeutic challenge. We present adjuvance with electron
therapy after surgical excision with curative intention.
Materials and methods. Since May – 2007, we treated 20 keloids in 19 patients. Mean age was 38.5 years (interval 16–80). Twelve
females and 8 males were irradiated with a maximum of 4h after surgery. The radiotherapy was delivered using a Clinac 2100
(Varian MS-Palo Alto). Beam energy was 6MeV, with a 4-mm thick aluminum foil 4-mm thick covering the end of the electron
applicator, used as a spoiler. Doses of 15Gy in 5 fractions of 300 cGy/d. were delivered. A 0.5 cm margin around the surgery
excision was included within the treatment ﬁeld, taking account that a thin lead mold should be placed around the scar on the
skin, at least 1 cm inside the optical ﬁeld in order to reduce the beam penumbra. To evaluate results and impact a photograph
was taken before surgery and at the beginning of therapy, and also every year during the follow up (follow-up interval: 4–68
months).
